(Indol-3-yl)-heterocycle derivatives as agonists of the cannabinoid CB1 receptor

Details for Australian Patent Application No. 2005224041 (hide)

Owner N.V. Organon

Inventors Adam-Worrall, Julia; Kiyoi, Takao; Morrison, Angus John; Wishart, Grant; Mcarthur, Duncan Robert

Agent Spruson & Ferguson

Pub. Number AU-B-2005224041

PCT Pub. Number WO2005/089754

Priority 04103901.7 12.08.04 EP; 60/550,563 05.03.04 US; 04100902.8 05.03.04 EP

Filing date 28 February 2005

Wipo publication date 29 September 2005

Acceptance publication date 10 March 2011

International Classifications

C07D 403/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 409/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 413/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 498/06 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 513/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or

Event Publications

21 September 2006 PCT application entered the National Phase

  PCT publication WO2005/089754 Priority application(s): WO2005/089754

15 February 2007 Assignment before Grant

  Akzo Nobel N.V. The application has been assigned to N.V. Organon

10 March 2011 Application Accepted

  Published as AU-B-2005224041

7 July 2011 Standard Patent Sealed

22 December 2011 Alteration of Name

  The name of the patentee has been altered to MSD Oss B.V.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005224043-Novel use for PDE5 inhibitors

2005224038-Cream-gel containing ivermectin